➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Moodys
McKinsey
AstraZeneca
Medtronic

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 5,840,581

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,840,581
Title: Process for somatic embryogenesis of sweetgum
Abstract:The present invention relates to an improved method for generating somatic embryos from mature plant tissue. The treatment methods of the present invention use a combination of disinfestation procedures and plant growth regulator compositions which induce unequal cell division. After forming and maturing the somatic embryos on suitable growth media, the mature somatic embryos are desiccated and cold stratified resulting in an dramatic increase in the percentage of somatic embryos which may be converted into plants.
Inventor(s): Carraway; Daniel T. (Bainbridge, GA), Merkle; Scott A. (Athens, GA)
Assignee: International Paper Company (Purchase, NY)
Application Number:08/626,235
Patent Claims:see list of patent claims

Details for Patent 5,840,581

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial International Paper Company (Purchase, NY) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial International Paper Company (Purchase, NY) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Dow
AstraZeneca
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.